Cite
COVID-19 in patients with lymphoproliferative diseases during the Omicron variant surge.
MLA
Bronstein, Yotam, et al. “COVID-19 in Patients with Lymphoproliferative Diseases during the Omicron Variant Surge.” Cancer Cell, vol. 40, no. 6, June 2022, pp. 578–80. EBSCOhost, https://doi.org/10.1016/j.ccell.2022.04.015.
APA
Bronstein, Y., Gat, R., Levi, S., Cohen, Y. C., Luttwak, E., Benyamini, N., Shragai, T., Vitkon, R., Neaman, M., Eilaty, N., Levi, M., Trestman, S., Perry, C., Herishanu, Y., & Avivi, I. (2022). COVID-19 in patients with lymphoproliferative diseases during the Omicron variant surge. Cancer Cell, 40(6), 578–580. https://doi.org/10.1016/j.ccell.2022.04.015
Chicago
Bronstein, Yotam, Roi Gat, Shai Levi, Yael C. Cohen, Efrat Luttwak, Noam Benyamini, Tamir Shragai, et al. 2022. “COVID-19 in Patients with Lymphoproliferative Diseases during the Omicron Variant Surge.” Cancer Cell 40 (6): 578–80. doi:10.1016/j.ccell.2022.04.015.